The HDAC inhibitor valproic acid (VPA), combined with the mTOR inhibitor temsirolimus, inhibited cell growth and triggered autophagic cell death in Burkitt’s lymphoma cell lines, primary tumor cells, and a murine xenograft model, reducing tumor growth [174]. This evidence concerns the gene HDAC9 and neoplasm.